CBG, short for cannabigerol, is a non-psychoactive cannabinoid with promising antibacterial, anti-inflammatory, and pain-relieving properties, though most evidence comes from lab and animal studies rather than human clinical trials. It won’t get you high, and early research suggests it’s well-tolerated even at higher doses. Here’s what the science actually supports so far.
How CBG Differs From CBD and THC
CBG is often called the “parent cannabinoid” because the cannabis plant produces it first, then enzymes convert most of it into THC, CBD, and other cannabinoids as the plant matures. By the time hemp is harvested, CBG typically makes up only about 1% of the plant’s cannabinoid content, which is why CBG products tend to cost more than CBD equivalents.
Unlike THC, CBG doesn’t produce a high. It interacts with the body’s endocannabinoid system differently than CBD does, binding more directly to both CB1 and CB2 receptors. This distinct receptor profile is why researchers believe CBG may offer benefits that CBD doesn’t, particularly for bacterial infections and gut inflammation.
Fighting Drug-Resistant Bacteria
The most striking evidence for CBG involves its ability to kill bacteria, including strains that resist conventional antibiotics. In laboratory testing published in the Journal of Applied Microbiology, CBG showed a minimum inhibitory concentration of just 1 mg/L against MRSA (methicillin-resistant Staphylococcus aureus), one of the most dangerous hospital-acquired infections. For context, that’s an impressively low amount needed to stop bacterial growth in a petri dish.
Multiple independent studies have confirmed this finding. CBG appears effective against several types of gram-positive bacteria, and when combined with silver compounds or other cannabinoids, the antibacterial effect becomes even stronger. This doesn’t mean CBG can replace antibiotics for an active infection right now, but it’s one of the more solid areas of CBG research and a reason pharmaceutical scientists are paying attention to it.
Gut Inflammation and Digestive Health
CBG has shown anti-inflammatory effects in the gut, which has generated interest around conditions like inflammatory bowel disease and colitis. Animal studies have found that CBG can reduce inflammation markers in colon tissue and improve symptoms in models of colitis.
There’s also an interesting “entourage” angle. Research published in The Journal of Pharmacology and Experimental Therapeutics found that combining small, individually ineffective doses of CBG with other non-psychoactive cannabinoids (like CBD and cannabichromene) reduced pain sensitivity related to colon inflammation. The combination worked at doses where none of the compounds did much on their own. This suggests CBG may be most useful for gut issues when paired with other cannabinoids rather than taken in isolation.
That said, no human clinical trials have confirmed these digestive benefits yet. People using CBG for gut symptoms are essentially experimenting based on preclinical data.
Eye Pressure and Glaucoma
CBG was one of the first cannabinoids studied for its effects on eye pressure, a key risk factor for glaucoma. Cannabinoids can lower intraocular pressure by activating specific receptors (CB1 and GPR18) in the eye’s drainage system, increasing fluid outflow. Animal studies have shown that topical cannabinoid application can reduce eye pressure by roughly 28% for up to eight hours.
The challenge is delivery. Cannabinoids don’t dissolve well in water-based eye drops, making it difficult to get enough of the compound into the eye. Researchers are working on improved formulations, but no CBG-based glaucoma treatment is available or close to approval. Standard glaucoma medications remain far more practical and proven.
Pain and Mood
Users frequently report that CBG helps with pain relief and anxiety, and there’s some biological basis for these claims. CBG interacts with receptors involved in pain signaling and appears to inhibit the breakdown of certain neurotransmitters that regulate mood. Some animal research supports mild analgesic and anti-anxiety effects.
However, this is the area where anecdotal reports run furthest ahead of the science. No controlled human trials have measured CBG’s effects on pain or anxiety with the rigor needed to make definitive claims. The subjective reports are consistent enough to be worth noting, but they’re not the same as clinical evidence.
Safety and Side Effects
CBG appears to be safe and well-tolerated. No lethal dose has been identified in humans, and serious adverse events haven’t been reported in the available research. If you take more than your body is comfortable with, the most common side effects are mild: dry mouth, drowsiness, dizziness, nausea, or temporary changes in blood pressure. These typically resolve within three to five hours as the compound clears your system.
One practical limitation: there are no established dosage guidelines from clinical trials. Most CBG products on the market suggest starting with 5 to 25 mg per day and adjusting from there. Because there’s no standardized dosing, the quality and potency of CBG products vary significantly between brands.
Legal Status in the U.S.
CBG occupies a somewhat clearer legal space than CBD. The FDA has specifically concluded that THC and CBD are excluded from the dietary supplement definition because they were first investigated as drug ingredients. CBG, however, has not been the subject of approved drug applications or major clinical investigations in the same way. The FDA has noted that cannabis-derived ingredients other than THC and CBD “might fall outside the scope of this exclusion” and could potentially be marketed as dietary supplements, provided they meet all other regulatory requirements.
In practice, CBG derived from hemp (containing less than 0.3% THC) is widely sold in the U.S. without federal enforcement action. But the FDA has not formally approved CBG for the treatment of any disease or condition, and products making specific health claims are technically in violation of federal regulations. If you’re buying CBG, look for products with third-party lab testing that confirms cannabinoid content and screens for contaminants like heavy metals and pesticides.